Evercore ISI analyst Liisa Bayko maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target ...

GSK has announced a new collaboration with local university and medical researchers, while Editas Medicine has a deal to ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

On Wednesday, Vertex Pharmaceuticals Incorporated (VRTX) stock saw a decline, ending the day at $470.05 which represents a decrease of $-4.86 or -1.02% from the prior close of $474.91. The stock ...

Nineteen companies are receiving $21.4 million total in tax incentive awards to create 1,155 new life sciences jobs in ...

The best time to visit Boston is from June to October. Mild autumn weather makes touring around on foot a joy. And even though summer brings in swarms of tourists and expensive hotel rates ...

The pharma market shows promise as gene therapy gains momentum through rapid advancements that address complex diseases and ...

Boston Scientific increased its annual profit forecast on Wednesday, fueled by strong demand for its cardiac implants, but temporarily halted a pivotal heart equipment study citing unexpected events.

Boston, Massachusetts-based Vertex Pharmaceuticals Incorporated (VRTX) develops and commercializes therapies for treating ...

The toymaker is considering a move to Boston and is reportedly looking at large blocks of office space near South Station and ...

Governor Maura Healey on Tuesday announced $21.4 million in tax incentives for life sciences companies that are expected to create 1,155 jobs in the state.

Two western Massachusetts life science companies are among 19 across the state to receive tax incentive awards.